Marilen Benner

SUMMARY AND DISCUSSION 239 8 99. Okubo H, Nakatsu Y, Kushiyama A, Yamamotoya T, Matsunaga Y, Inoue M-k, et al. Gut microbiota as a therapeutic target for metabolic disorders. Current medicinal chemistry. 2018;25(9):984-1001. 100. Brahe LK, Le Chatelier E, Prifti E, Pons N, Kennedy S, Blædel T, et al. Dietary modulation of the gut microbiota – a randomised controlled trial in obese postmenopausal women. British Journal of Nutrition. 2015;114(3):406-17. 101. Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 2003;189(1):139-47. 102. Kurki T, Sivonen A, Renkonen O-V, Savia E, Ylikorkala O. Bacterial Vaginosis in Early Pregnancy and Pregnancy Outcome. Obstetrics and gynecology. 1992;80(2):173-7. 103. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2007(1). 104. Koedooder R, Singer M, Schoenmakers S, Savelkoul PHM, Morré SA, de Jonge JD, et al. The ReceptIVFity cohort study protocol to validate the urogenital microbiome as predictor for IVF or IVF/ICSI outcome. Reprod Health. 2018;15(1):202. 105. Koedooder R, Singer M, Schoenmakers S, Savelkoul PHM, Morré SA, de Jonge JD, et al. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study. Human reproduction (Oxford, England). 2019;34(6):1042-54. 106. Saxtorph MH, Hallager T, Persson G, Petersen KB, Eriksen JO, Larsen LG, et al. Assessing endometrial receptivity after recurrent implantation failure: a prospective controlled cohort study. Reproductive biomedicine online. 2020;41(6):998-1006. 107. Kyono K, Hashimoto T, Kikuchi S, Nagai Y, Sakuraba Y. A pilot study and case reports on endometrial microbiota and pregnancy outcome: An analysis using 16S rRNA gene sequencing among IVF patients, and trial therapeutic intervention for dysbiotic endometrium. Reprod Med Biol. 2019;18(1):72-82. 108. Gilstrap LC, 3rd, Ramin SM. Urinary tract infections during pregnancy. Obstet Gynecol Clin North Am. 2001;28(3):581-91. 109. Easter SR, Cantonwine DE, Zera CA, Lim K-H, Parry SI, McElrath TF. Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia. Am J Obstet Gynecol. 2016;214(3):387. e1-.e7. 110. Izadi B, Rostami-Far Z, Jalilian N, Khazaei S, Amiri A, Madani SH, et al. Urinary tract infection (UTI) as a risk factor of severe preeclampsia. Glob J Health Sci. 2016;8(11):54364. 111. Yan L, Jin Y, Hang H, Yan B. The association between urinary tract infection during pregnancy and preeclampsia: A meta-analysis. Medicine. 2018;97(36):e12192-e. 112. Tormo ‐ Badia N, Håkansson Å, Vasudevan K, Molin G, Ahrne S, Cilio C. Antibiotic Treatment of Pregnant Non ‐ Obese Diabetic Mice Leads to Altered Gut Microbiota and Intestinal Immunological Changes in the Offspring. Scand J Immunol. 2014;80(4):250-60. 113. Lapin B, Piorkowski J, Ownby D, Freels S, Chavez N, Hernandez E, et al. Relationship between prenatal antibiotic use and asthma in at-risk children. Ann Allergy Asthma Immunol. 2015;114(3):203-7.